Voyager Therapeutics (VYGR) Reports Q1 Loss, Lags Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of$ 0.35. This compares to loss of $0.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -51.43%. A quarter ago, it was expected that this gene therapy company would post a loss of$ 0.35 per share when it actually produced a loss of $0.59, delivering a surprise of -68.57%.Over the last four quarters, the ...